The analyst rating for BEONE MEDICINES is "Outperform" based on several key factors highlighted in the article. The company turned around from a significant loss in the previous quarter to a net profit that exceeded market expectations, reporting a profit of $125 million in 3Q25 compared to the consensus estimate of $80 million. Additionally, total product revenue for the quarter increased by 40% year-over-year, aligning with the broker's forecasts. CCBI also raised its target price for the stock, reflecting a positive outlook based on a sum-of-the-parts valuation method and discounted cash flow analysis, which suggests that the stock is undervalued compared to its peers in the biotech sector.

Valuation Metrics

The current forward P/E ratio for (06160.HK) is 48.54, compared to its 5-year average forward P/E of 2.66. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

2.66

Current PE

48.54

Overvalued PE

70.80

Undervalued PE

-65.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-7.85

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

20.73

Undervalued EV/EBITDA

-36.43

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

11.66

Current PS

0.00

Overvalued PS

20.44

Undervalued PS

2.89

Financials

AI Analysis

Annual

Quarterly

Whales Holding 06160

Trading Trends

People Also Watch

Frequently Asked Questions

What is (06160) stock price today?

The current price of 06160 is 175 USD — it has decreased -1.91

What is (06160)'s business?

What is the price predicton of 06160 Stock?

Wall Street analysts forecast 06160 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 06160 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (06160)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (06160)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (06160). have?

(06160) has 0 emplpoyees as of March 04 2026.

What is (06160) market cap?

Today 06160 has the market capitalization of 0.00 USD.

06160 Overview